Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Radionetics Oncology Enters Into Strategic Agreement With Lilly
Radionetics Oncology Enters Into Strategic Agreement With Lilly
Radionetics Oncology Enters Into Strategic Agreement With Lilly
Submitted by
admin
on July 1, 2024 - 11:16am
Source:
Businesswire
News Tags:
Eli Lilly
Radionetics Oncology
radiopharmaceuticals
M&A
Headline:
Radionetics Oncology Enters Into Strategic Agreement With Lilly
snippet:
Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals
Radionetics to receive $140 million upfront payment
Lilly obtains the exclusive right to acquire Radionetics for $1 billion
Do Not Allow Advertisers to Use My Personal information
